Joanne E. Nash
Affiliations: | Cell and Systems Biology | University of Toronto, Toronto, ON, Canada |
Area:
Neuroscience BiologyGoogle:
"Joanne Nash"Mean distance: 53433
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Trinh D, Israwi AR, Brar H, et al. (2023) Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy. Neurobiology of Disease. 106287 |
Trinh D, Israwi AR, Arathoon LR, et al. (2020) The multi-faceted role of mitochondria in the pathology of Parkinson's disease. Journal of Neurochemistry |
Gleave JA, Arathoon LR, Trinh D, et al. (2018) Corrigendum to "Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism" [Neurobiol. Dis. 106 (2018) 133-146]. Neurobiology of Disease |
Lu JYD, Su P, Barber JEM, et al. (2017) The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage. Peerj. 5: e3933 |
Arathoon LR, Gleave JA, Trinh D, et al. (2017) Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism. Neurobiology of Disease |
Thiele SL, Chen B, Lo C, et al. (2014) Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models. Neurobiology of Disease. 71: 334-44 |
Gleave JA, Perri PD, Nash JE. (2014) Mitochondrial dysfunction in Parkinson’s disease: a possible target for neuroprotection Frontiers in Biology. 9: 489-503 |
Yong-Kee CJ, Warre R, Monnier PP, et al. (2012) Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in parkinson's disease Neurotoxicity Research. 22: 355-364 |
Thiele SL, Warre R, Nash JE. (2012) Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease. Journal of Visualized Experiments : Jove |
Johnston TH, Millar Z, Huot P, et al. (2012) A novel MDMA analogue, UWA-101, that lacks psychoactivity and cytotoxicity, enhances L-DOPA benefit in parkinsonian primates. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 26: 2154-63 |